z-logo
open-access-imgOpen Access
Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders
Author(s) -
Mi Kwon,
Rebeca Bailén,
Pascual Balsalobre,
Manuel Jurado,
Arancha Bermúdez,
Jon Badiola,
Albert Esquirol,
Pilar Miralles,
Elisa López-Fernández,
Jaime Sanz,
Lucrecia Yáñez,
Mercedes Colorado,
José Luís Piñana,
Nieves Dorado,
Laura Solán,
Carolina Martínez-Laperche,
Ismael Buño,
Javier Anguita,
David Serrano,
José L. Díez-Martín,
Grupo Español de Trasplante Hematopoyético y Terapia Celular
Publication year - 2019
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000002209
Subject(s) - medicine , hematopoietic stem cell transplantation , transplantation , population , disease , immunology , environmental health
Although a number of patients with HIV infection and hematological disease have successfully undergone allogeneic hematopoietic stem-cell transplantation (HSCT), short and long-term outcomes remain not well known. We report the largest Spanish experience treating HIV-infected adult patients with high-risk hematological malignancies with allogeneic HSCT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here